Literature DB >> 18083120

Epidermal growth factor (EGF) receptor targeted delivery of PEGylated adenovirus.

Ji Won Park1, Hyejung Mok, Tae Gwan Park.   

Abstract

A biotin-polyethylene glycol (PEG)-epidermal growth factor (EGF) conjugate was immobilized onto the surface of avidin-modified adenovirus (ADV-Avi) via biotin-avidin interaction to deliver ADV specifically to EGF receptor over-expressing cancer cells. ADV-Avi/biotin-PEG-EGF complexes showed greatly enhanced intracellular uptake of ADV particles for an EGF receptor positive cell line (A431 cells), compared to naked or PEG alone immobilized ADV. ADV coding an exogenous GFP gene was used to quantitatively evaluate the level of GFP expression. ADV-Avi/biotin-PEG-EGF complexes also exhibited significantly increased extent of GFP expression for A431 cells, but not for MCF-7 cells (an EGF receptor deficient cell line), suggesting that retargeting of ADV to specific cells occurred by tethering of a cell-specific targeting ligand to the distal end of a PEG chain anchored onto the surface of ADV. This study demonstrates that ADV-Avi/biotin-PEG-EGF construct systems can be applied for cell-specific delivery of ADV with simultaneously reducing innate immune responses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18083120     DOI: 10.1016/j.bbrc.2007.12.045

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

Review 1.  Enhancing the therapeutic efficacy of adenovirus in combination with biomaterials.

Authors:  Jaesung Kim; Pyung-Hwan Kim; Sung Wan Kim; Chae-Ok Yun
Journal:  Biomaterials       Date:  2011-12-03       Impact factor: 12.479

2.  Tumor vascular targeted delivery of polymer-conjugated adenovirus vector for cancer gene therapy.

Authors:  Xinglei Yao; Yasuo Yoshioka; Tomohiro Morishige; Yusuke Eto; Shogo Narimatsu; Yasuaki Kawai; Hiroyuki Mizuguchi; Jian-Qing Gao; Yohei Mukai; Naoki Okada; Shinsaku Nakagawa
Journal:  Mol Ther       Date:  2011-06-14       Impact factor: 11.454

Review 3.  Adenoviral vector immunity: its implications and circumvention strategies.

Authors:  Yadvinder S Ahi; Dinesh S Bangari; Suresh K Mittal
Journal:  Curr Gene Ther       Date:  2011-08       Impact factor: 4.391

Review 4.  Directing systemic oncolytic viral delivery to tumors via carrier cells.

Authors:  Hiroshi Nakashima; Balveen Kaur; E A Chiocca
Journal:  Cytokine Growth Factor Rev       Date:  2010-03-11       Impact factor: 7.638

Review 5.  Superparamagnetic iron oxide nanoparticle-based delivery systems for biotherapeutics.

Authors:  Hyejung Mok; Miqin Zhang
Journal:  Expert Opin Drug Deliv       Date:  2012-12-01       Impact factor: 6.648

6.  Increasing the efficacy of oncolytic adenovirus vectors.

Authors:  Karoly Toth; William S M Wold
Journal:  Viruses       Date:  2010-08-27       Impact factor: 5.818

7.  PEGylated Adenoviruses: From Mice to Monkeys.

Authors:  Piyanuch Wonganan; Maria A Croyle
Journal:  Viruses       Date:  2010-02-01       Impact factor: 5.818

8.  Retargeting of viruses to generate oncolytic agents.

Authors:  M H Verheije; P J M Rottier
Journal:  Adv Virol       Date:  2011-11-14

9.  Targeting the EGF receptor for ovarian cancer therapy.

Authors:  Reema Zeineldin; Carolyn Y Muller; M Sharon Stack; Laurie G Hudson
Journal:  J Oncol       Date:  2009-12-28       Impact factor: 4.375

10.  New clathrin-based nanoplatforms for magnetic resonance imaging.

Authors:  Gordana D Vitaliano; Franco Vitaliano; Jose D Rios; Perry F Renshaw; Martin H Teicher
Journal:  PLoS One       Date:  2012-05-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.